Volcanics Venture is a venture capital firm established in 2016, headquartered in Shanghai, China, with an additional office in Beijing. The firm focuses on investing in start-up, early, and growth stages of companies primarily within the technology, media, telecommunications, internet innovation, smart technology, cloud technology, healthcare, and biomedicine sectors. Volcanics Venture aims to identify and support promising companies and entrepreneurs, particularly in advanced technology-driven healthcare and intelligence applications, including genomics, proteomics, microbiology, and artificial intelligence. The firm's managing partners, Suyang Zhang, Yeshun Dong, and Ying Wu, bring over 60 years of combined experience in venture capital investment and corporate management, offering a blend of global insights and local expertise to enhance the value of their portfolio companies.
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui.
Unisic Technology
Series B in 2024
Unisic specializes in the design and manufacturing of silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including power modules and driver circuits. Unisic's technology finds applications across various sectors, such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By focusing on customized application solutions, Unisic aims to enhance the performance and efficiency of power systems in these critical fields.
Unisic Technology
Venture Round in 2023
Unisic specializes in the design and manufacturing of silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including power modules and driver circuits. Unisic's technology finds applications across various sectors, such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By focusing on customized application solutions, Unisic aims to enhance the performance and efficiency of power systems in these critical fields.
Fengtai Technology
Series B in 2023
Fengtai Technology is a company that specializes in industrial information security, focusing on providing professional and standardized safety consulting and evaluation services for chemical control. Its primary goal is to ensure the security of key industrial information infrastructures and enhance security protection solutions. Fengtai serves a diverse clientele, including government agencies, industry customers, design institutes, research organizations, integrators, and hardware and software manufacturers. The company employs visual, process-oriented, and customized tools and methods to assist users in implementing effective risk management strategies and reliable operational support. Additionally, Fengtai develops industrial control and security software solutions aimed at improving operational oversight and safety, with a strong emphasis on evaluating and designing safety guarantee systems and enterprise risk management frameworks.
GenLight Medical
Venture Round in 2023
Genlight is a company based in Hangzhou, China, that specializes in developing advanced treatment solutions for epilepsy and other neurological disorders. The organization focuses on innovative technologies in the field of brain science and neurosurgery, creating laser medical equipment designed to improve patient outcomes. Genlight's offerings include brain-computer control technology, deep brain nerve stimulation with full-cranial implantation, brain computer chips, and a minimally invasive surgery system guided by magnetic resonance. These high-tech solutions aim to provide patients with effective and cutting-edge surgical options for neurological conditions.
Fabrie
Seed Round in 2022
Fabrie is a cloud-based collaboration software designed specifically for designers, offering tools that enhance team communication and facilitate real-time synchronization. It includes a range of modifiable design templates, allowing users to easily customize their projects without the frustration of searching through non-editable options. The platform supports multi-person collaboration and features capabilities for associating tables and diagrams, along with cloud storage and sharing functionalities. By streamlining the design process, Fabrie aims to improve collaboration efficiency among teams.
Aiagain
Series B in 2022
Aiagain provides contact module, data marketing, content radar, risk control inspection, data connection, batch labeling, automatic risk control, assets, and protecting services.
Baibaojun
Seed Round in 2022
Baibaojun operates an intelligent insurance service platform that leverages artificial intelligence, big data, and cloud computing to enhance the insurance industry. The company provides users with a wealth of insurance industry news and trends while disseminating valuable insurance knowledge. By promoting and facilitating connections between consumers and insurance consultants, Baibaojun assists in transforming the traditional dynamics of the insurance market. This approach shifts the focus from a sales-oriented model to a more passive supply chain, allowing users to find the most suitable insurance products and consultants tailored to their specific needs. Through collaborations with industry partners, Baibaojun aims to reshape the relationship between supply and demand in the insurance sector.
Fabrie
Seed Round in 2022
Fabrie is a cloud-based collaboration software designed specifically for designers, offering tools that enhance team communication and facilitate real-time synchronization. It includes a range of modifiable design templates, allowing users to easily customize their projects without the frustration of searching through non-editable options. The platform supports multi-person collaboration and features capabilities for associating tables and diagrams, along with cloud storage and sharing functionalities. By streamlining the design process, Fabrie aims to improve collaboration efficiency among teams.
FlowUs
Angel Round in 2022
FlowUs is a provider of a productivity software that offers an integrated platform for information organization and collaboration. The company’s solutions combine documents, tables, folders, and real-time cloud collaboration, allowing individuals and teams to manage their digital information efficiently. By utilizing cloud notes and various multi-functional tools, FlowUs serves as a comprehensive work center that enhances productivity and streamlines collaboration in both personal and professional environments.
Ideamake
Series C in 2022
Ideamake is a VR viewing solution provider that builds a virtual house environment through virtual reality technology. The house scene is composed of digital models of real data, follows engineering design standards and requirements, and reproduces the planned project. To help users choose the decoration style that suits them.
BOOLV
Series A in 2022
BOOLV is a software-as-a-service (SaaS) provider specializing in AI-driven video generation. The company focuses on creating automatic short marketing videos, primarily catering to e-commerce clients in sectors such as fashion and furniture. By utilizing big data and artificial intelligence, BOOLV generates engaging video clips designed for marketing purposes. The company has established successful collaborations with a variety of well-known brands across different industries, including academia. BOOLV aims to deliver comprehensive video marketing solutions that enhance the online presence and promotional efforts of its clients.
Enze Kangtai
Series A in 2022
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
Yunli Smart Technology
Series A in 2021
Yunli Wisdom is a digital transformation service provider for government and enterprises. It uses cloud computing, big data, Internet of Things, artificial intelligence, and blockchain as its core technologies. It focuses on government affairs, finance, transportation, manufacturing, ecological environment and other fields, and is committed to providing Application software and services empowered by new technologies.
Alluxio
Series C in 2021
Alluxio, Inc. is a provider of a memory-centric distributed storage system that facilitates unified data access across various applications and underlying storage systems. Founded in 2015 and based in Berkeley, California, the company emerged from an open-source project developed at UC Berkeley's AMPLab. Alluxio's platform enhances data orchestration, enabling analytics and machine learning operations in cloud environments by relocating data closer to compute resources. This architecture supports memory-speed access to files and objects, benefiting sectors such as financial services, retail, and telecommunications. The company has established a strategic collaboration with Intel to further advance its technology and offerings.
Thinktech
Series A in 2021
Thinktech is a design and manufacturing company that specializes in producing automotive-grade semiconductors. They provide automotive security designed for ICV applications with built-in hardware. The company focuses on providing comprehensive security solutions to the Chinese automotive sector.
Space Transportation
Venture Round in 2021
Space Transportation is engaged in designing and manufacturing space transport systems with the goal of reducing the costs associated with space exploration. The company focuses on the development of reusable commercial space transport vehicles, which are intended to lower commercial launch expenses related to reentry and carrier recycling. Through its innovative approach, Space Transportation aims to make space access more economical and efficient, contributing to the broader field of commercial space travel.
BaishanCloud
Venture Round in 2021
BaishanCloud, founded in April 2015, is a provider of cloud-managed services that focuses on cloud resource exchanges and interactions. The company offers a comprehensive suite of services, including cloud delivery, cloud storage, and cloud linkages, designed to meet the diverse needs of enterprise customers. BaishanCloud emphasizes data governance and utilizes analytics-driven security policies and intelligent caching algorithms to ensure the security of data in transit. Its cloud management platform facilitates data migration, integration, acceleration, and analytics, effectively supporting clients in navigating multi-cloud infrastructures. With its innovative approach, BaishanCloud aims to enhance the efficiency and effectiveness of cloud services for businesses.
Huleen
Angel Round in 2021
Huleen is committed to opening up application boundaries and bringing together more information.
Dynasty Gene
Series A in 2021
Dynasty Gene specializes in synthetic biology technology and offers biotechnology consulting services aimed at advancing next-generation DNA sequencing (NGS). The company is dedicated to technology development, consulting, transfer, and technical services within the biotechnology sector. It holds independent intellectual property rights for its Micropore high-throughput DNA synthesis platform, which has enabled the launch of a range of products, including liquid biopsy solutions and NGS library capture kits. Through its innovative approach and proprietary technology, Dynasty Gene aims to facilitate significant advancements in the field of biotechnology.
Zenlayer
Series C in 2021
Zenlayer Inc. is a technology company based in Diamond Bar, California, specializing in global connectivity solutions for enterprises. Founded in 2014, Zenlayer provides a software-defined network and services that include bare metal cloud, SD-WAN cloud connect, edge computing, and colocation services across more than 100 data centers on six continents. Its platform allows businesses to deploy and manage IT resources efficiently, enhancing digital experiences and reducing latency. By leveraging Zenlayer's services, enterprises can achieve instant worldwide connectivity, facilitating smoother operations and improved user experiences.
Phanes Therapeutics
Series B in 2021
Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. The company specializes in drug discovery and early development, primarily in the fields of immuno-oncology and eye diseases. Phanes Therapeutics is developing a range of therapeutic molecules, including a monoclonal antibody aimed at treating solid tumors, as well as therapies for age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, the company is working on bispecific antibodies targeting small cell lung cancer. Through its extensive scientific expertise and innovative approaches, Phanes Therapeutics aims to create effective treatment options that enhance patient care and improve outcomes for those suffering from various conditions.
Alpha Cen
Seed Round in 2021
Alpha Cen is a developer of wafer-level metasurface light control chips and modules. It offers a semiconductor IC-compatible process to integrate micro-nano optical metasurfaces with circuits, light sources, and photodetectors.
Koka Lifesciences
Venture Round in 2021
Koka Lifesciences specializes in the research, development, production, and distribution of medical devices aimed at addressing structural heart disease. The company develops a range of interventional devices, including heart valves and valve repair equipment, which are designed to enhance surgical efficiency and improve patient outcomes. Through its focus on innovation in cardiovascular care, Koka Lifesciences aims to shorten operation times and increase the success rates of heart-related procedures.
Hexcloud
Series A in 2020
Hexcloud is the next generation of retail digital middle end technology. Their products include a platform as a service, an omni channel fulfillment platform, a global marketing center, and a store supply chain platform. Hexcloud platform integrates retail chain store operational data covering sales, supply chain, and finance and offers centralized business intelligence for retail stores.
Vision Medicals Technology
Series B in 2020
Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.
Brite Semiconductor
Series D in 2020
Brite Semiconductor, Inc. is a custom ASIC and system-on-chip (SoC) design company founded in 2008 and headquartered in Shanghai, China, with additional offices in the United States, Europe, Japan, and Taiwan. The company specializes in providing a comprehensive range of services, including design, manufacturing, and turnkey solutions for silicon products. Brite Semiconductor's offerings encompass a silicon proven IP portfolio known as YouIP, which includes YouPHY, YouRF, and YouSiP, designed to assist customers in efficiently transitioning from product specification to silicon. The firm employs advanced technologies to optimize IP, foundry, and packaging processes, aiming to deliver high-quality, cost-effective solutions with reduced time to market. With a focus on customer needs, Brite Semiconductor also supports clients through third-party manufacturing services, product OEM solutions, and extensive customer support. Its innovative MAX technology enhances yield and minimizes costs, making it a reliable partner for various ASIC and SoC requirements.
Cloudpick
Series A in 2020
Cloudpick Technology is a high-tech company focused on developing computer vision and artificial intelligence applications, particularly for the retail industry. It offers innovative AI solutions that include a patented behavior recognition and product learning algorithm engine. This technology enables accurate identification of product information and customer shopping behaviors, facilitating convenient shopping experiences such as "Grab and Go" and seamless payment options. Cloudpick aims to advance the application of artificial intelligence and big data analysis across various sectors, enhancing operational efficiency and customer satisfaction in retail environments.
Polaris Biology
Series B in 2020
Polaris Biology is a medical technology company focused on the development and clinical application of cell-level precision diagnostic technology. The company aims to enhance tumor diagnosis and treatment by studying individual and dynamic changes in tumors at the cellular level. Utilizing artificial intelligence algorithms and drug-system biological models, Polaris Biology provides advanced diagnostic tools designed to offer direct and accurate clinical support for cancer treatment. These innovations are intended to empower both patients and physicians in making informed decisions regarding cancer care.
Deep Mirror
Seed Round in 2020
Deep Mirror is a startup developing state-of-the-art spatial intelligence technology and creating a multi-layer digital twin of the real world. It offers competitive rewards, equal promotion opportunities, and access to the most cutting-edge technology towards spatial intelligence.
Alluxio
Series B in 2020
Alluxio, Inc. is a provider of a memory-centric distributed storage system that facilitates unified data access across various applications and underlying storage systems. Founded in 2015 and based in Berkeley, California, the company emerged from an open-source project developed at UC Berkeley's AMPLab. Alluxio's platform enhances data orchestration, enabling analytics and machine learning operations in cloud environments by relocating data closer to compute resources. This architecture supports memory-speed access to files and objects, benefiting sectors such as financial services, retail, and telecommunications. The company has established a strategic collaboration with Intel to further advance its technology and offerings.
Hannto Technology
Series B in 2020
Hannto Technology Inc. is a Shanghai-based company founded in 2017 that specializes in the development of smart devices and Internet of Things (IoT) applications. The company focuses on designing and manufacturing intelligent hardware and image output products, particularly mobile printers. One of its flagship offerings is XPRINT, a mobile photo printer that allows users to print directly from their mobile devices. Hannto Technology is committed to enhancing the consumer printing experience by providing high-quality products that align with users' printing habits and needs, while also emphasizing design, research and development, production, and sales in the printing sector.
RootPath Genomics
Series A in 2020
RootPath Genomics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in developing a personalized T-cell therapy platform that integrates precision medicine with cancer immunotherapy. The company's innovative technologies focus on the analysis and manipulation of individual immune cells, enabling advancements in immune and cell therapy. By precisely monitoring and modulating the immune system, RootPath aims to enhance the diagnosis and treatment of cancer, contributing to significant improvements in patient outcomes.
Saints & Sages
Venture Round in 2020
Saints & Sages Medical specializes in the production and sale of minimally invasive surgical medical devices. The company offers a range of energy device products utilized across various medical fields, including hepatobiliary surgery, gynecology, urology, thoracic surgery, thyroid and breast surgery, and gastrointestinal surgery. By closely monitoring clinical needs, Saints & Sages is committed to developing innovative surgical devices that enhance the accuracy and efficiency of procedures. The company is supported by a dedicated research and development team with extensive experience in clinical transformation, allowing it to continually advance its offerings to better serve patients worldwide.
Space Transportation
Seed Round in 2019
Space Transportation is engaged in designing and manufacturing space transport systems with the goal of reducing the costs associated with space exploration. The company focuses on the development of reusable commercial space transport vehicles, which are intended to lower commercial launch expenses related to reentry and carrier recycling. Through its innovative approach, Space Transportation aims to make space access more economical and efficient, contributing to the broader field of commercial space travel.
CaiCloud
Series B in 2019
Caicloud is a private company based in Hangzhou, China, specializing in cloud computing and artificial intelligence. Founded in July 2015, Caicloud has developed a Kubernetes-based Cluster-as-a-Service (CaaS) platform, enhancing its offerings with features such as security management, DevOps capabilities, and application orchestration. The latest iteration, CaaS 2.0, integrates with public clouds in China and supports on-premise infrastructures, serving numerous Fortune 500 companies. Additionally, Caicloud introduced TensorFlow-as-a-Service (TaaS), which operates on its CaaS, providing a comprehensive "Cloud + AI" solution that includes automatic anomaly detection and data-driven troubleshooting. The company also contributes to the open-source community by maintaining Kubernetes projects and has released tools like Cyclone, a Kubernetes-native CI/CD project, further demonstrating its commitment to advancing cloud computing technologies.
Eoitek Technology
Series B in 2019
Eoitek is a provider of intelligent big data analysis solutions, specializing in the development and delivery of AIOps, an innovative product designed to enhance operation and maintenance processes. The company utilizes artificial intelligence and big data technologies to help clients uncover the value of their operational data, facilitating digital transformation across various sectors, including banking, insurance, manufacturing, energy, and transportation. Founded in 2014 and headquartered in Shanghai, China, Eoitek offers its solutions through both onsite deployments and subscription service models, allowing enterprises to efficiently collect, process, analyze, and display multi-dimensional operational data, including fault events, performance indicators, logs, and maintenance work orders.
Naxions
Series B in 2019
Beijing Naxions Technology Co., Ltd. specializes in digital marketing services tailored for the medical Internet sector. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, the company has developed a communication software solution that incorporates a SaaS platform. This platform enables real-time data analysis, progress visualization, and results digitization, thereby enhancing sales management for pharmaceutical companies. Naxions offers a range of services, including data capture, collection, scraping, cleaning, calculation, and presentation. Key features of its application include content sharing, project management, and customer analysis, all aimed at improving the efficiency and brand visibility of pharmaceutical enterprises while ensuring compliance with industry standards.
Beijing Gene+ Technology
Series B in 2019
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of offerings, including clinical testing, medical device manufacturing, and scientific cooperation services. It plays a significant role in supporting precision medicine by delivering critical data for treatment planning. Beijing Gene+ Technology operates in approximately 100 hospitals and has served thousands of cancer patients across China, contributing to advancements in personalized healthcare solutions.
Ruixun Biotech
Series A in 2019
Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.
RainSure Scientific
Series A in 2019
RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.
Vision Medicals Technology
Series A in 2019
Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.
Furrytail
Series A in 2019
Furrytail is a designer and manufacturer of innovative pet lifestyle products, focusing on enhancing the quality of life for pets through modern, minimalist designs at affordable prices. The company specializes in a range of items including pet clothing, cat sleepers, food bowls, and cat mints, among other accessories. By targeting the younger cat population with high life cycle value, Furrytail aims to build a strong brand community and capture market share. The firm emphasizes the importance of understanding consumer needs and developing products that cater to the full life cycle value of cats, thereby fostering incremental user demand.
Dynasty Gene
Series A in 2019
Dynasty Gene specializes in synthetic biology technology and offers biotechnology consulting services aimed at advancing next-generation DNA sequencing (NGS). The company is dedicated to technology development, consulting, transfer, and technical services within the biotechnology sector. It holds independent intellectual property rights for its Micropore high-throughput DNA synthesis platform, which has enabled the launch of a range of products, including liquid biopsy solutions and NGS library capture kits. Through its innovative approach and proprietary technology, Dynasty Gene aims to facilitate significant advancements in the field of biotechnology.
Zenlayer
Series B in 2019
Zenlayer Inc. is a technology company based in Diamond Bar, California, specializing in global connectivity solutions for enterprises. Founded in 2014, Zenlayer provides a software-defined network and services that include bare metal cloud, SD-WAN cloud connect, edge computing, and colocation services across more than 100 data centers on six continents. Its platform allows businesses to deploy and manage IT resources efficiently, enhancing digital experiences and reducing latency. By leveraging Zenlayer's services, enterprises can achieve instant worldwide connectivity, facilitating smoother operations and improved user experiences.
Fourier Intelligence
Series B in 2019
Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.
AIMON
Series C in 2019
Aimon is a designer and manufacturer of animation derivative products based in Shanghai, China. The company specializes in the development and design of various cultural and creative items, including toy models, clothing, office stationery, suitcases, and daily consumables. Aimon collaborates with well-known animation brands, primarily from Japan and Taiwan, to create products that resonate with anime enthusiasts. By acquiring intellectual property rights from original creators, Aimon offers a range of corresponding merchandise that caters to the interests of fans in both domestic and international markets.
OncXerna Therapeutics
Series B in 2019
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.
LenoMed Medical
Series C in 2019
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.
SpaceTouch
Series A in 2019
Zhuhai Pulin Core Technology Co., Ltd. specializes in developing advanced 3D gesture interfaces aimed at enhancing human-computer interaction. Founded by experts in electrical engineering, the company leverages its extensive research and development experience to create innovative solutions in the field of integrated circuits. Its non-touch air gesture recognition technology, which is based on capacitive sensing, enables users to interact with smartphones and other devices through intuitive air gestures. This technology supports a range of applications across various industries, including consumer electronics, wearable devices, digital signage, smart furniture, and the automotive sector. Through its commitment to advancing gesture-based interfaces, the company positions itself as a leader in the growing market of interactive technology.
Polaris Biology
Series A in 2019
Polaris Biology is a medical technology company focused on the development and clinical application of cell-level precision diagnostic technology. The company aims to enhance tumor diagnosis and treatment by studying individual and dynamic changes in tumors at the cellular level. Utilizing artificial intelligence algorithms and drug-system biological models, Polaris Biology provides advanced diagnostic tools designed to offer direct and accurate clinical support for cancer treatment. These innovations are intended to empower both patients and physicians in making informed decisions regarding cancer care.
eMeet
Venture Round in 2019
eMeet specializes in creating advanced audio technology for voice collaboration, focusing on enhancing the quality of conferencing devices. The company has developed an AI-driven noise reduction algorithm that powers its innovative speakerphones. These devices are designed to improve audio performance during calls by integrating features such as background noise and echo suppression, sound capture through artificial intelligence, and automatic volume adjustment. This technology allows users to filter human voices and significantly reduce background noise, ensuring clear and natural two-way conversations even in challenging environments. eMeet's products aim to elevate the audio experience for professionals engaged in virtual communication.
Aiqi Technology
Series B in 2018
Beijing AIQI Technology Co., Ltd. is an Internet technology company focused on the research and development of artificial intelligence and robotic technology. The company has assembled a team of enthusiastic and innovative individuals dedicated to exploring advancements in intelligent equipment, resulting in the acquisition of numerous patents over the past three years. A notable achievement includes a partnership with a prominent technology firm, positioning AIQI as the sole provider of DIY intelligent robots within that company's ecosystem. AIQI specializes in creating interactive DIY family robots designed for K-12 STEM education, leveraging advanced AI technology to enhance human-machine interaction. Their products are user-friendly, updatable, and aim to inspire creativity while providing engaging experiences for users in modern life.
Furrytail
Seed Round in 2018
Furrytail is a designer and manufacturer of innovative pet lifestyle products, focusing on enhancing the quality of life for pets through modern, minimalist designs at affordable prices. The company specializes in a range of items including pet clothing, cat sleepers, food bowls, and cat mints, among other accessories. By targeting the younger cat population with high life cycle value, Furrytail aims to build a strong brand community and capture market share. The firm emphasizes the importance of understanding consumer needs and developing products that cater to the full life cycle value of cats, thereby fostering incremental user demand.
Geek+
Series B in 2018
Geek+ specializes in the development of autonomous mobile robots aimed at enhancing warehouse, factory, and supply chain management. The company leverages advanced robotics and artificial intelligence to create customized solutions across various sectors, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. By providing reliable products and comprehensive after-sales services, Geek+ assists major brands in optimizing their logistics operations. It has emerged as a leading provider of logistics robots in China, serving a diverse clientele that includes e-commerce platforms, third-party logistics providers, and manufacturers in sectors such as apparel, pharmaceuticals, and electronics. Additionally, Geek+ has formed strategic partnerships with key customers to collaboratively develop tailored AI and robotic solutions, addressing the specific needs of different industries.
Urban Fable Basketball Club (Beijing)
Series A in 2018
Urban Fable Basketball Club (Beijing) Co is a sports company.
GJS Robot
Series B in 2018
GJS Robot specializes in the development of consumer battle robots and gaming robots that leverage artificial intelligence and advanced technology. The company designs customized fighting robots intended for competition, incorporating features such as servo motors and wheels. Their products are equipped with infrared cameras and deep learning capabilities, allowing for enhanced performance and man-machine synchronization control. Through its innovative approach, GJS Robot aims to provide clients with cutting-edge robotic solutions for engaging in robot combat competitions.
RootPath Genomics
Seed Round in 2018
RootPath Genomics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in developing a personalized T-cell therapy platform that integrates precision medicine with cancer immunotherapy. The company's innovative technologies focus on the analysis and manipulation of individual immune cells, enabling advancements in immune and cell therapy. By precisely monitoring and modulating the immune system, RootPath aims to enhance the diagnosis and treatment of cancer, contributing to significant improvements in patient outcomes.
Shebaotong
Series B in 2018
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.
Maia Active
Series A in 2018
Maia Active is an athleisure sportswear brand focused on creating stylish and functional clothing for Asian girls. The company designs and manufactures sportswear that emphasizes comfort, lightweight materials, and motivation for active lifestyles. By catering specifically to the needs and preferences of fashionable young women, Maia Active aims to enhance the sports experience, allowing customers to look good while participating in various physical activities.
Ruixun Biotech
Seed Round in 2018
Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.
ImageDT
Series A in 2018
ImageDT is an enterprise services company specializing in image recognition and semantic analysis technology. It offers solutions that enhance product modeling, improve recognition accuracy, and facilitate comprehensive data collection. The company's tools enable offline inventory management, e-commerce monitoring, and insights into public opinion, helping businesses identify growth opportunities. By providing instant reports and actionable intelligence, ImageDT equips brands to gain a competitive edge in the market.
IPSTAR
Seed Round in 2018
IPSTAR is a Media & Entertainment Start up.
Aiagain
Series A in 2018
Aiagain provides contact module, data marketing, content radar, risk control inspection, data connection, batch labeling, automatic risk control, assets, and protecting services.
OncXerna Therapeutics
Seed Round in 2018
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.
Sandieji
Series A in 2018
A Medical technology Company based in Nanjing,China.
Triastek
Series A in 2018
Triastek specializes in the development of 3D printed medicines and the associated manufacturing facilities. The company is focused on innovating pharmaceutical 3D printing technology to enhance the design, development, and production of pharmaceutical products. Triastek has created proprietary technology that encompasses the entire process, from pharmaceutical dosage form design to digital development and continuous production. This approach aims to revolutionize drug delivery and manufacturing solutions within the medical industry. Additionally, Triastek has filed patent applications to protect its technological advancements.
YingLink
Series A in 2018
YingLink is a company that focuses on enhancing the grading and diagnosis of medical products through its innovative cloud-based platform. This platform is designed to facilitate improved communication among radiologists, bolster diagnostic knowledge, and enhance medical imaging skills. By enabling radiologists to work remotely, YingLink aims to streamline the diagnostic process and elevate the standards of medical imaging in the industry.
XPECT Vision
Series B in 2018
Xpect Vision, founded in 2015, is a high-tech company specializing in the development of innovative medical imaging technologies. The company focuses on photon-counting X-ray imaging and is advancing the field with the creation of high-speed, high-definition imaging chips. Xpect Vision manufactures imaging chips that utilize digital X-ray imaging technology and CMOS X-ray detection methods, which are designed to enhance medical detection services. These products aim to improve the accuracy of cancer diagnoses, enabling physicians to deliver more efficient and effective healthcare solutions. Through its commitment to disruptive technology development, Xpect Vision is positioning itself as a leader in the future of imaging technology.
Innovative Cellular Therapeutics
Series B in 2018
Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, focused on the research and development of cell therapy. Established in 2009, the company specializes in creating chimeric antigen receptor T (CAR-T) products aimed at treating blood cancers and solid tumors. Its portfolio includes an allogeneic CAR-T development program utilizing gene editing and gene therapy techniques. The company is dedicated to developing cellular immunotherapies for late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and enhancing quality of life for those affected by cancer.
Eoitek Technology
Series A in 2018
Eoitek is a provider of intelligent big data analysis solutions, specializing in the development and delivery of AIOps, an innovative product designed to enhance operation and maintenance processes. The company utilizes artificial intelligence and big data technologies to help clients uncover the value of their operational data, facilitating digital transformation across various sectors, including banking, insurance, manufacturing, energy, and transportation. Founded in 2014 and headquartered in Shanghai, China, Eoitek offers its solutions through both onsite deployments and subscription service models, allowing enterprises to efficiently collect, process, analyze, and display multi-dimensional operational data, including fault events, performance indicators, logs, and maintenance work orders.
TRON
Angel Round in 2018
TRON is a technology company that specializes in developing artificial intelligence solutions aimed at enhancing third-level and fourth-level autonomous driving functions in the automotive sector. Founded in 2017 and headquartered in Shanghai, China, with an additional office in California, TRON focuses primarily on innovations related to automobile Engine Control Units (ECUs). By addressing critical aspects of vehicle automation, TRON aims to contribute to advancements in self-driving technology.
Aishen Medical
Series A in 2018
Aishen Medical (爱肾医疗) is a SaaS-based platform that offers kidney disease management services, particularly for patients with chronic kidney diseas. It focuses on the provision of popular science and chronic disease management services for patients with kidney disease.
Ishen365
Series A in 2018
Ishen365 is a Shanghai-based company that develops and operates a renal care service platform tailored for the healthcare sector. The company specializes in providing chronic disease management solutions specifically for patients with kidney disease. Through its online platform, Ishen365 offers clinical management services that address various renal conditions, ensuring that clients receive comprehensive support in managing their health.
Dadao
Series B in 2018
Car sharing platform
Genus Finance
Series A in 2018
Genus Finance, established in 2015 and headquartered in Shanghai, China, specializes in algorithmic trading tools and quantitative investment solutions. The company focuses on delivering safe, efficient, and cost-effective trading strategies tailored for financial institutions, including public funds, private equity, and securities firms. Its product offerings include a range of algorithmic trading strategies such as G-TWAP, G-VWAP, G-Percent, G-PxlnLine, G-Sniper, and G-DMA+. These algorithms cater to various trading needs, from time-weighted and volume-weighted average pricing to price tracking and quick execution, positioning Genus Finance as a key player in the algorithmic trading sector.
Fourier Intelligence
Series A in 2018
Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.
Polaris Biology
Seed Round in 2018
Polaris Biology is a medical technology company focused on the development and clinical application of cell-level precision diagnostic technology. The company aims to enhance tumor diagnosis and treatment by studying individual and dynamic changes in tumors at the cellular level. Utilizing artificial intelligence algorithms and drug-system biological models, Polaris Biology provides advanced diagnostic tools designed to offer direct and accurate clinical support for cancer treatment. These innovations are intended to empower both patients and physicians in making informed decisions regarding cancer care.
Polaris Technology
Seed Round in 2018
Polaris Technology i provides biomedical research institutes with cloud services of computational visualization and analysis specific to heterogeneous biomedical data. Our services are delivered to stakeholders through cloud-based deep learning models, cross-platform interactive data analysis systems, and crowd-sourcing data platforms.
Shanghai STEM Cloud
Series A in 2018
Shanghai STEM Cloud specializes in providing an internet platform focused on STEM (Science, Technology, Engineering, and Math) education. The company collaborates with professional societies, associations, and research institutions to offer authoritative and professional STEM solutions. By integrating educational resources from both domestic and international sources, Shanghai STEM Cloud delivers online classes, tools, labs, and competitions designed to enhance the STEM learning experience for students. Additionally, the company provides professional training aimed at uncovering teaching and research opportunities in the field.
Lingyi Zhihui
Venture Round in 2018
Zuoshouyisheng's AI doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.
Senslab
Venture Round in 2018
Senslab is a developer of artificial intelligence technology focused on creating visual appliances. The company produces AI chips and algorithm software, with a product line that includes face recognition cameras, intelligent security cameras, and smart doorbells. These offerings are designed to provide enterprises with low-power and cost-effective security solutions, making advanced artificial intelligence products more accessible to a broader audience.
Geneplus-Beijing
Venture Round in 2018
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.
IPMBiotech
Venture Round in 2018
IPMBiotech focuses on the development and application of precision medical technology and cell therapy technology.
Future Vision
Venture Round in 2018
Future Vision is a visual health service organization based in Shanghai, specializing in the prevention and control of myopia, amblyopia rehabilitation training, and medical optometry for children aged 3 to 16. The company utilizes advanced North American optometry technology to deliver its services, aiming to address the growing concerns of visual health among children. By focusing on early intervention and comprehensive eye care, Future Vision seeks to improve the visual outcomes for its young clientele.
WeShine
Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.
Health Biotech
Angel Round in 2017
Health Biotech is a research and development firm specializing in precision medicine through the application of mass spectrometry. The company focuses on early diagnosis, treatment, and monitoring of Alzheimer's disease, employing liquid chromatography-mass spectrometry techniques to quantitatively detect specific biomarkers associated with the condition. By offering comprehensive solutions that include tools, equipment, and reagent consumables, Health Biotech aims to provide reliable detection services for patients. Its innovative technology not only aids in identifying risks for Alzheimer's disease but also supports healthcare professionals in enhancing patient outcomes by delaying disease onset and improving cognitive abilities.
Keyin Tech
Series A in 2017
Keyin Tech is a technology and service research and development enterprise specializing in the medical field. The company focuses on physical robotics and cloud technology platforms, offering solutions aimed at enhancing surgical procedures and patient care. Keyin Tech develops virtual reality solutions for surgeries, clinical analysis, and rehabilitation training. Its primary systems include a pre-surgery platform planning tool, a surgery navigator, and robotics designed to assist surgeons. These innovations aim to improve communication between surgeons and patients while minimizing the risk of surgical accidents.
Geek+
Series B in 2017
Geek+ specializes in the development of autonomous mobile robots aimed at enhancing warehouse, factory, and supply chain management. The company leverages advanced robotics and artificial intelligence to create customized solutions across various sectors, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. By providing reliable products and comprehensive after-sales services, Geek+ assists major brands in optimizing their logistics operations. It has emerged as a leading provider of logistics robots in China, serving a diverse clientele that includes e-commerce platforms, third-party logistics providers, and manufacturers in sectors such as apparel, pharmaceuticals, and electronics. Additionally, Geek+ has formed strategic partnerships with key customers to collaboratively develop tailored AI and robotic solutions, addressing the specific needs of different industries.
Xiaodupi
Series C in 2017
Xiaodupi is a developer of mobile applications focused on social engagement and personal development for young girls. One of its key products is the Little Belly app, a weight loss application that utilizes health technology to synchronize user weight data and create personalized weight loss plans. Additionally, Xiaodupi offers a social media and gaming application that targets girls under the age of fourteen, gamifying career learning and social growth. This platform encourages interaction by providing virtual fashion items as incentives, fostering both educational and social experiences for its users.
Geek+
Series A in 2017
Geek+ specializes in the development of autonomous mobile robots aimed at enhancing warehouse, factory, and supply chain management. The company leverages advanced robotics and artificial intelligence to create customized solutions across various sectors, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. By providing reliable products and comprehensive after-sales services, Geek+ assists major brands in optimizing their logistics operations. It has emerged as a leading provider of logistics robots in China, serving a diverse clientele that includes e-commerce platforms, third-party logistics providers, and manufacturers in sectors such as apparel, pharmaceuticals, and electronics. Additionally, Geek+ has formed strategic partnerships with key customers to collaboratively develop tailored AI and robotic solutions, addressing the specific needs of different industries.
Jianke
Series A in 2017
Jianke is anonline B2C pharmacy and healthcare services platform.
Xiao Dengta
Series A in 2017
Xiao Dengta provides career advancement and career development solutions.
Manhuadao
Series A in 2016
Manhuadao is an online platform dedicated to comic book reading and community engagement. It offers a diverse selection of comics across various genres, including original works from emerging comic artists. The platform not only serves as a repository for comic series but also fosters interaction among comic enthusiasts through its community forum. Manhuadao aims to build a comprehensive animation industry chain by collaborating with enterprises across multiple sectors, including novels, comics, animation, film, television, and gaming. By creating a fun and interactive environment, the company enhances the overall experience for comic fans while promoting non-commercial sharing and communication within its community.
OrigiMed
Angel Round in 2016
OrigiMed Inc., based in Shanghai, China, specializes in research and clinical support services for cancer patients. The company focuses on developing innovative technologies and clinical applications aimed at improving cancer treatment. By utilizing comprehensive, high-throughput methodologies and extensive bioinformatics analysis, OrigiMed identifies cancer-specific molecular markers and genomic features. This information is crucial for guiding targeted therapies and immunotherapies, contributing to advancements in precision medicine for cancer care. Through its efforts, OrigiMed aims to enhance the effectiveness of cancer treatments and support the evolution of personalized medicine in China.
CreditX
Series A in 2016
CreditX is a provider of financial services. They offer machine learning, finance risk management, big data analysis, and finance consulting services. Intelligent risk control, intelligent transaction monitoring, customer management, and intelligent customer service are among its business fields.
Shebaotong
Series A in 2016
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.
Geek+
Series A in 2016
Geek+ specializes in the development of autonomous mobile robots aimed at enhancing warehouse, factory, and supply chain management. The company leverages advanced robotics and artificial intelligence to create customized solutions across various sectors, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. By providing reliable products and comprehensive after-sales services, Geek+ assists major brands in optimizing their logistics operations. It has emerged as a leading provider of logistics robots in China, serving a diverse clientele that includes e-commerce platforms, third-party logistics providers, and manufacturers in sectors such as apparel, pharmaceuticals, and electronics. Additionally, Geek+ has formed strategic partnerships with key customers to collaboratively develop tailored AI and robotic solutions, addressing the specific needs of different industries.
Anjie IOT
Venture Round in 2016
Anjie IoT is a technological innovation firm specializing in IoT solutions for utilities management, focusing on sectors such as public infrastructure. The company develops technologies that monitor the usage and condition of systems including air conditioning, electricity, fire protection, and building security, thereby enhancing the efficiency of maintenance tasks. With a commitment to "carbon peaking and carbon neutrality," Anjie IoT emphasizes advancing industry through scientific and technological progress while contributing to national goals. As a high-tech enterprise and a member of the International Fog Computing Alliance, Anjie IoT aims to provide energy safety and economic solutions that align with contemporary environmental objectives.
Xiaodupi
Series B in 2015
Xiaodupi is a developer of mobile applications focused on social engagement and personal development for young girls. One of its key products is the Little Belly app, a weight loss application that utilizes health technology to synchronize user weight data and create personalized weight loss plans. Additionally, Xiaodupi offers a social media and gaming application that targets girls under the age of fourteen, gamifying career learning and social growth. This platform encourages interaction by providing virtual fashion items as incentives, fostering both educational and social experiences for its users.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.